Salvage Cryotherapy in Recurrent Prostate Cancer

Stopped early

Conditions studied: Recurrent Prostate Cancer

In brief

To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term efficacy and safety of this procedure. Ultimately the data analysis will serve as a robust guidance instrument for improving upon the utilization of this procedure for the treatment of patients with recurrent (LRD) prostate cancer.

Key facts

Study ID

NCT00824928

Run by

University of Colorado, Denver

People needed

60

Starts

2007-01-01

Expected to finish

2012-12-01

Last updated by the study team

2015-05-27

Who can join

Age: 30 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Read \& understand informed consent related to this study including consenting and HIPPA authorization
• Undergone salvage cryotherapy of the prostate for recurrent prostate cancer

You may not qualify if…

• Patients who underwent radical prostatectomy as their primary therapy or other significant surgery (except prostatic biopsy)
• Patients with clinically confirmed distant metastasis (unless deemed beneficial by the treating physician)
• Any previous major rectal surgery
• Clinically significant lower urinary tract or rectal anomalies
• Existing urethral, rectal, or bladder fistulae

Where it is running

• Loma Linda University — Loma Linda, California, United States
• Kaiser Permanente — Sacremento, California, United States
• Prostate Institute of America — Ventura, California, United States
• University of Colorado at Denver and Health Sciences Center — Aurora, Colorado, United States
• Lakeland Regional Cancer Center — Lakeland, Florida, United States
• Rush University Medical Center — Chicago, Illinois, United States
• Midwest Urology/RMD Clinical Research — Melrose Park, Illinois, United States
• Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Methodist Hospital — Brooklyn, New York, United States
• Nelson Stone (private practice) — New York, New York, United States
• Riverside Urology, Inc. — Columbus, Ohio, United States
• Rhode Island Hospital/Warren Alpert Medical School of Brown University — Providence, Rhode Island, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• University of Tennessee Cancer Institute - Memphis — Memphis, Tennessee, United States
• Urology Associates of North Texas — Arlington, Texas, United States
• Urology of Virginia, Sentara Medical Group — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.